High frequency of the 472AA COMT (Val158) homozygous genotype of the catechol-O-methyltransferase (COMT) gene in children with irritable bowel syndrome

Authors

DOI:

https://doi.org/10.15574/SP.2022.126.23

Keywords:

irritable bowel syndrome, children, biopsychosocial model, catechol-O-methyltransferase gene, COMT, allelic polymorphism

Abstract

Following the biopsychosocial model of medicine, the pathophysiological basis of irritable bowel syndrome (IBS) is a combination of biological, psychoemotional, and psychosocial factors, the contribution of each of them to the development of this disorder remains unclear. Psychoemotinal factors, which are involved in the pathogenesis of IBS, are caused not only by the environment but also by the metabolism of catecholamines, particularly by the functional activity of catechol-O-methyltransferase (COMT).

Purpose - to determine the role of Val158Met COMT polymorphism in development of IBS in children; to identify associations between genotype and clinical variant of the disorder and the nature of the provoking factor.

Materials and methods. The material for the molecular genetic study were DNA samples obtained from nuclear cells of venous blood of 54 patients aged 6-12 years with diagnosed IBS. In 48 practically healthy children of the same age DNA samples were isolated from buccal epithelial cells. Molecular genetic study of single nucleotide polymorphism rs4680 of COMT gene was performed by polymerase chain reaction followed by analysis of restriction fragment length polymorphism. Microsoft Excel 2016 and GraphPad Prism 5 software were used for statistical analysis.

Results. We have revealed significant differences in the distribution of Val158Met COMT genotypes in children with IBS in comparison with the control group. There was established that the 472GА COMT is more prevalent in healthy children and has a protective role in the development of IBS. In contrast, homozygous genotypes 472GG and 472AA, which are associated with changes in functional activity of enzyme COMT, may be considered as the risk factors for IBS (p≤0.0001).

Conclusions. Genotype 472АА COMT was mostly detected in сhildren with stress-associated IBS, which is more related to dysnociception, disorders of cognition, and emotional disturbances. The higher prevalence of 472GA COMT heterozygotes among children with postinfectious IBS and IBS associated with antibiotic therapy indicates a less important role for the psychoemotional component and nociceptive disorders in the onset of this disorder (p=0.03).

The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of all participating institutions. The informed consent of the patient was obtained for conducting the studies.

No conflict of interests was declared by the authors.

References

Devanarayana NM, Rajindrajith S. (2018). Irritable bowel syndrome in children: Current knowledge, challenges and opportunities. World Journal Gastroenterology. 24 (21): 2211-2235. https://doi.org/10.3748/wjg.v24.i21.2211; PMid:29881232 PMCid:PMC5989237

Gazouli M, Wouters MM, Kapur-Pojskić L, Bengtson MB et al. (2016). Lessons learned-resolving the enigma of genetic factors in IBS. Nature Reviews Gastroenterology & Hepatology. 13 (2): 77-87. https://doi.org/10.1038/nrgastro.2015.206; PMid:26726033

Hall KT, Lembo AJ, Kirsch I, Ziogas DC, Douaiher J et al. (2012). Catechol-O-Methyltransferase val158met Polymorphism Predicts Placebo Effect in Irritable Bowel Syndrome. PLoS One. 7 (10): 1-6. https://doi.org/10.1371/journal.pone.0048135; PMid:23110189 PMCid:PMC3479140

Han CJ, Kohen R, Jun S, Jarrett ME, Cain KC, Burr R, Heitkemper MM. (2017). COMT Val158Met Polymorphism and Symptom Improvement Following a Cognitively Focused Intervention for Irritable Bowel Syndrome. Nursing Research. 66 (2): 75-84. https://doi.org/10.1097/NNR.0000000000000199; PMid:28252569 PMCid:PMC5334775

Heitkemper MM, Kohen R, Jun SE, Jarrett ME. (2011). Genetics and gastrointestinal symptoms. Annual Review of Nursing Research. 29: 261-280. https://doi.org/10.1891/0739-6686.29.261; PMid:22891508

Karling P, Danielsson Å, Wikgren M, Söderström I, Del-Favero J, Adolfsson R, Norrback KF. (2011). The relationship between the Val158Met catechol-O-methyltransferase (COMT) polymorphism and irritable bowel syndrome. PLoS One. 6 (3): 1-5. https://doi.org/10.1371/journal.pone.0018035; PMid:21437260 PMCid:PMC3060919

Makker J, Chilimuri S, Bella JN. (2015). Genetic epidemiology of irritable bowel syndrome. World Journal of Gastroenterology. 21 (40): 11353-11361. https://doi.org/10.3748/wjg.v21.i40.11353; PMid:26525775 PMCid:PMC4616211

Martin C, Osadchiy V, Kalani A, Mayer E. (2018). The Brain-Gut-Microbiome Axis. Cellular and Molecular Gastroenterology and Hepatology. 6 (2): 133-148. https://doi.org/10.1016/j.jcmgh.2018.04.003; PMid:30023410 PMCid:PMC6047317

Oka P, Parr H, Barberio B, Black CJ, Savarino EV, Ford AC. (2020). Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology. 5 (10): 908-917. https://doi.org/10.1016/S2468-1253(20)30217-X; PMid:32702295

Radovanovic-Dinic B, Tesic-Rajkovic S, Grgov S, Petrovic G, Zivkovic V. (2018). Irritable bowel syndrome - from etiopathogenesis to therapy. Biomedical Papers. 162 (1): 1-9. https://doi.org/10.5507/bp.2017.057; PMid:29358788

Serrano JM, Banks JB, Fagan TJ, Tartar JL. (2019). The influence of Val158Met COMT on physiological stress responsivity. Stress. 22 (2): 276-279. https://doi.org/10.1080/10253890.2018.1553949; PMid:30628551

Shadryn OG, Platonova OM. (2013). Monitoring of irritable bowel syndrome prevalence in child population of Ukraine. Sovremennaya pediatriya. 4 (52): 84-87.

Solonko HM, Smoljar NI, Turkys MJ, Makukh HV. (2015). Molecular and genetic analysis of polymorphous variants val158met of the comt gene in children who need dental treatment under the general ahesthesia. ScienceRise. 8/3 (13): 71-75. https://doi.org/10.1037/0022-006X.74.3.568; PMid:16822113

Van Oudenhove L, Levy RL, Crowell MD, Drossman DA et al. (2016). Biopsychosocial Aspects of Functional Gastrointestinal Disorders: How Central and Environmental Processes Contribute to the Development and Expression of Functional Gastrointestinal Disorders. Gastroenterology. 150 (6): 1355-1367. https://doi.org/10.1053/j.gastro.2016.02.027; PMid:27144624 PMCid:PMC8809487

Wang Y, Wu Z, Qiao H, Zhang Y. (2014). A genetic association study of single nucleotide polymorphisms in GNΒ3 and COMT in elderly patients with irritable bowel syndrome. Medical Science Monitor. 20: 1246-1254. https://doi.org/10.12659/MSM.890315; PMid:25037115 PMCid:PMC4113520

Witte AV, Flöel A. (2012). Effects of COMT polymorphisms on brain function and behavior in health and disease. Brain Research Bulletin. 88 (5): 418-428. https://doi.org/10.1016/j.brainresbull.2011.11.012; PMid:22138198

Zubieta JK, Heitzeg MM, Smith YR, Bueller JA et al. (2003). COMT val158 genotype affects μ-opioid neurotransmitter responses to a pain stressor. Science. 299 (5610): 1240-1243. https://doi.org/10.1126/science.1078546; PMid:12595695

Published

2022-10-29

Issue

Section

Original articles